Skip to main content

REDES NEURONALES EN CHIPS DE MICROFLUIDOS PARA EL ESTUDIO DE ENFERMEDADES NEURONALES CON PROPAGACION PROTEICA

PCIN-2013-065

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos Programación Conjunta Internacional
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

An amino acid substitution found in animals with low susceptibility to prion diseases confers a protective dominant-negative effect in prion-infected transgenic mice

  • Otero García, Alicia
  • Bolea Bailo, Rosa
  • Hedman Altamirano, Carlos
  • Fernández-Borges, Natalia
  • Marín González, María Belén
  • López Pérez, Óscar
  • Barrio Alegre, Tomás
  • Eraña, Hasier
  • Sánchez-Martín, Manuel A.
  • Monzón Garcés, Marta
  • Badiola Díez, Juan José
  • Castilla, Joaquín
While prion diseases have been described in numerous species, some, including those of the Canidae family, appear to show resistance or reduced susceptibility. A better understanding of the factors underlying prion susceptibility is crucial for the development of effective treatment and control measures. We recently demonstrated resistance to prion infection in mice overexpressing a mutated prion protein (PrP) carrying a specific amino acid substitution characteristic of canids. Here, we show that coexpression of this mutated PrP and wild-type mouse PrP in transgenic mice inoculated with different mouse-adapted prion strains (22 L, ME7, RML, and 301C) significantly increases survival times (by 45 to 113%). These data indicate that this amino acid substitution confers a dominant-negative effect on PrP, attenuating the conversion of PrPC to PrPSc and delaying disease onset without altering the neuropathological properties of the prion strains. Taken together, these findings have important implications for the development of new treatment approaches for prion diseases based on dominant-negative proteins.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Unraveling the key to the resistance of canids to prion diseases

  • Fernández-Borges, Natalia
  • Parra, Beatriz|||0000-0002-5371-7449
  • Vidal Barba, Enric|||0000-0002-4965-3286
  • Eraña, Hasier|||0000-0001-8776-4211
  • Sánchez-Martín, Manuel A.|||0000-0001-8370-1336
  • de Castro, Jorge|||0000-0002-2380-8956
  • Elezgarai, Saioa R.|||0000-0001-7054-9689
  • Pumarola i Batlle, Martí|||0000-0002-0935-7941
  • Mayoral, Tomás|||0000-0003-2644-1966
  • Castilla, Joaquín|||0000-0002-2216-1361
One of the characteristics of prions is their ability to infect some species but not others and prion resistant species have been of special interest because of their potential in deciphering the determinants for susceptibility. Previously, we developed different in vitro and in vivo models to assess the susceptibility of species that were erroneously considered resistant to prion infection, such as members of the Leporidae and Equidae families. Here we undertake in vitro and in vivo approaches to understand the unresolved low prion susceptibility of canids. Studies based on the amino acid sequence of the canine prion protein (PrP), together with a structural analysis in silico, identified unique key amino acids whose characteristics could orchestrate its high resistance to prion disease. Cell- and brain-based PMCA studies were performed highlighting the relevance of the D163 amino acid in proneness to protein misfolding. This was also investigated by the generation of a novel transgenic mouse model carrying this substitution and these mice showed complete resistance to disease despite intracerebral challenge with three different mouse prion strains (RML, 22L and 301C) known to cause disease in wild-type mice. These findings suggest that dog D163 amino acid is primarily, if not totally, responsible for the prion resistance of canids. Detection of individuals or whole species resistant to any infectious disease is vital to understand the determinants of susceptibility and to develop appropriate therapeutic and preventative strategies. Canids have long been considered resistant to prion infection given the absence of clinical disease despite exposure to the causal agent. Through extensive analysis of the canine prion protein we have detected a key amino acid that might be responsible for their universal resistance to prion disease. Using in vitro and in vivo models we demonstrated that the presence of this residue confers resistance to prion infection when introduced to susceptible animals, opening the way to develop a new therapeutic approach against these, at present, untreatable disorders.